Some Veterans Affairs (VA) medical centers are beginning to treat substance use disorders and mental illness together, The Columbus Dispatch reports. Until recently, VA hospitals tended to treat the two problems separately.
Category results for "Prescription Drugs"
The Ohio Attorney General’s office is investigating complaints that some people are abusing drugs prescribed for pets, or intentionally abusing animals to obtain painkillers.
The attorneys general from 28 states are asking the Food and Drug Administration (FDA) to reassess its decision to approve Zohydro ER (extended release), a pure form of the painkiller hydrocodone. Earlier this month, four U.S. senators told the FDA Commissioner Margaret Hamburg they disagree with the agency’s decision to approve the drug.
The American College of Physicians, one of the nation’s largest medical groups, has released a set of recommendations about how doctors can help reduce prescription drug abuse.
Four U.S. senators told the Commissioner of the Food and Drug Administration they disagree with the agency’s decision to approve a pure version of the painkiller hydrocodone, Newsday reports.
When kids come into treatment, their lives are just chaotic. Parents are desperate — they don’t know what to do or where to turn. The most important thing is to bring stability into the situation, and the best way to do that is with medication, says Dr. John Knight.
Slightly less than 1 percent of anesthesiology residents in the United States have a substance use disorder, according to a new study. The incidence of substance use has been increasing, and relapse rates are not improving, the researchers said.
A new government report finds about 6 percent of U.S. teens say they use a psychiatric medicine as drug therapy, similar to the rate 10 years ago.
A study of opioid-dependent patients entering drug-treatment programs across the country finds oxycodone is the most popular prescription opioid to abuse because of the quality of the high the drug produces.
Last June, I testified before a Reference Committee at the annual meeting of the American Medical Association, explaining a resolution that American Society of Addiction Medicine had brought forward to encourage the Food and Drug Administration to reschedule hydrocodone combination products from Schedule III to Schedule II. I expected there to be few others testifying. I wasn’t at all ready for the long line of individuals standing at the “con” microphone, ready to speak against the resolution, says Dr. Stuart Gitlow, ASAM President.